Jinhai Medical Technology Limited (HKG:2225)

Hong Kong · Delayed Price · Currency is HKD

6.03

+0.16 (2.64%)

Sep 15, 2026, 11:55 AM HKT

Jinhai Medical Technology Financials Overview

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	65.77	46.28	50.24	45.64	22.28	21.9
Revenue Growth	42.12%	-7.89%	10.07%	104.87%	1.75%	-2.56%
Gross Profit	11.73	7.19	11.48	12.03	10.12	7.73
Operating Income	-10.96	-18.01	-20.09	-4.59	-	-1.43
Net Income	-11.19	-17.08	-17.97	-3.14	0.47	-0.25
Earnings Per Share	-0.00	-0.00	-0.00	-0.00	0.00	-0.00
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Services	16.31	24.31	25.21	21.62	20.34
Products	29.96	25.93	20.43	0.66	1.56
Total	46.28	50.24	45.64	22.28	21.9

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	34.56	38.88	17.26	30.1	26.06	25.91
Total Debt	14.21	14.91	14.52	10.08	4.45	1.87
Net Cash (Debt)	20.34	23.97	2.73	20.01	21.61	24.04
Net Cash Growth	-15.12%	776.99%	-86.34%	-7.37%	-10.14%	17.57%
Net Cash Per Share	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	-5.57	-3.26	-1.91	4.24	3.34
Capital Expenditures	-	-0.1	-1.01	-1.24	-1.18	-0.61
Free Cash Flow	-	-5.66	-4.26	-3.15	3.06	2.73
Free Cash Flow Growth	-	-	-	-	12.12%	-62.30%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	17.83%	15.53%	22.84%	26.35%	45.40%	35.29%
Operating Margin	-16.66%	-38.92%	-39.98%	-10.06%	-	-6.55%
Pretax Margin	-14.35%	-37.09%	-36.28%	-7.05%	3.52%	-0.28%
Profit Margin	-17.01%	-36.91%	-35.76%	-6.88%	2.10%	-1.12%
FCF Margin	-	-12.23%	-8.49%	-6.89%	13.75%	12.48%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	985.27	-
P/FCF Ratio	-	-	-	-	150.54	217.95
PS Ratio	78.05	23.61	34.35	11.39	20.70	27.20